институт онкологии гюмосква

The data of the first intermediate analysis of results of research BCRIG01 are published, in which comparison of efficiency of standard mode FAC (500/50/500) with a таксан-containing mode (with inclusion Таксотера) ТАС (75/50/500 (1) is lead{carried out}. Both modes were used with an interval of 3 weeks in quantity{amount} of 6 rates. This first published research estimating a role доцетаксела (Таксотера) in адъювантной of therapy of a cancer dairy железы. Earlier in two other researches (С9344 and В30) the role паклитаксела has been investigated, and one of them (С9344) has shown increase безрецидивной and the general{common} survival rate at patients with рецептороотрицательными tumours at use паклитаксела is consecutive with a mode the EXPERT. Подробнее...

With increase in quantity{amount} of people of elderly and senile age, decrease{reduction} in death rate from other diseases, неминуемо desease a cancer and death rate from him{it} will grow. Under forecasts of the World organization of public health services (CART) desease and death rate oncological diseases all over the world will increase in 2 times for the period since 1999 for 2020: with 10 up to 20 million new cases and with 6 up to 12 million registered death. Подробнее...